AU2002354433A1 - Alzheimer's disease-associated gene and protein and use thereof - Google Patents

Alzheimer's disease-associated gene and protein and use thereof

Info

Publication number
AU2002354433A1
AU2002354433A1 AU2002354433A AU2002354433A AU2002354433A1 AU 2002354433 A1 AU2002354433 A1 AU 2002354433A1 AU 2002354433 A AU2002354433 A AU 2002354433A AU 2002354433 A AU2002354433 A AU 2002354433A AU 2002354433 A1 AU2002354433 A1 AU 2002354433A1
Authority
AU
Australia
Prior art keywords
alzheimer
protein
disease
associated gene
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002354433A
Inventor
Hiroto Komano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAPAN AS REPRESENTED BY SECRETARY OF CHUBU NATIONAL HOSPITAL
Takeda Pharmaceutical Co Ltd
Original Assignee
Agency of Industrial Science and Technology
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology, Takeda Chemical Industries Ltd filed Critical Agency of Industrial Science and Technology
Publication of AU2002354433A1 publication Critical patent/AU2002354433A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
AU2002354433A 2001-12-06 2002-12-05 Alzheimer's disease-associated gene and protein and use thereof Abandoned AU2002354433A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001373050 2001-12-06
JP2001-373050 2001-12-06
PCT/JP2002/012749 WO2003048204A1 (en) 2001-12-06 2002-12-05 Alzheimer’s disease-associated gene and protein and use thereof

Publications (1)

Publication Number Publication Date
AU2002354433A1 true AU2002354433A1 (en) 2003-06-17

Family

ID=19181834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002354433A Abandoned AU2002354433A1 (en) 2001-12-06 2002-12-05 Alzheimer's disease-associated gene and protein and use thereof

Country Status (2)

Country Link
AU (1) AU2002354433A1 (en)
WO (1) WO2003048204A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
DK2142514T3 (en) 2007-04-18 2015-03-23 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
AU2010294214B2 (en) 2009-09-11 2015-05-07 Vivoryon Therapeutics N.V. Heterocylcic derivatives as inhibitors of glutaminyl cyclase
JP6026284B2 (en) 2010-03-03 2016-11-16 プロビオドルグ エージー Inhibitors of glutaminyl cyclase
AU2011226074B2 (en) 2010-03-10 2015-01-22 Vivoryon Therapeutics N.V. Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
JP6050264B2 (en) 2011-03-16 2016-12-21 プロビオドルグ エージー Benzimidazole derivatives as inhibitors of glutaminyl cyclase
PL3461819T3 (en) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitors of glutaminyl cyclase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058356A1 (en) * 1999-03-26 2000-10-05 Human Genome Sciences, Inc. 50 human secreted proteins

Also Published As

Publication number Publication date
WO2003048204A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2002336288A1 (en) Weed controller metabolism proteins, genes thereof and use of the same
AU2002258728A1 (en) Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
AU2002354433A1 (en) Alzheimer's disease-associated gene and protein and use thereof
AU2003285346A1 (en) Regulatory elements in the 5' region of the vr1 gene
AU2002319460A1 (en) Improvement of gene expression in vectors
AU2002302247A1 (en) Genes and proteins involved in the biosynthesis of enediyne ring structures
AU2002240921A1 (en) Medane genes and proteins
AUPR595601A0 (en) Hypoglycaemic peptides and methods of use thereof
AU2003280992A1 (en) Novel proteins and use thereof
AU2003292774A1 (en) Novel proteins and use thereof
AU2001296584A1 (en) Alzheimer's disease-associated proteins
AU2002360333A1 (en) Human angiomotin-like protein 1
AU2002357609A1 (en) Novel proteins and dnas thereof
AU2002351616A1 (en) Lipase genes and proteins
AU2001234150A1 (en) Novel protein and gene encoding the same
AU2002210960A1 (en) Novel disease-associated gene and use thereof
AU2002311205A1 (en) Novel disease-associated gene and use thereof
AU2001255763A1 (en) 13295 novel protein kinase molecules and uses therefor
EP1428877A4 (en) Novel protein and dna thereof
AUPR589701A0 (en) Novel peptide and use thereof
AU2002230137A1 (en) Novel protein and use thereof
AU2002352698A1 (en) Immune-related proteins and the regulation of the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase